11.78

12.40% 1.30

After Hours: 11.80 0.02 +0.17%

Bioventus Inc (BVS)

Overview News Price History Option Chain Financials Discussions Forecast

Bioventus Inc stock is traded at $11.78, with a volume of 1.54M. It is up +12.40% in the last 24 hours and up +30.31% over the past month. Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Previous Close:

$10.48

Open:

$10.55

24h Volume:

1.54M

Relative Volume:

2.60

Market Cap:

$798.07M

Revenue:

$568.09M

Net Income/Loss:

$27.27M

P/E Ratio:

35.96

EPS:

0.3276

Net Cash Flow:

$71.41M

1W Performance:

+20.45%

1M Performance:

+30.31%

6M Performance:

+53.99%

1Y Performance:

+67.81%

1-Day Range:

$10.49

$11.96

1-Week Range:

$9.28

$11.96

52-Week Range:

$5.81

$11.96

Bioventus Inc Stock (BVS) Company Profile

Name

Bioventus Inc

Sector

Healthcare (1100)

Industry

Medical Devices (142)

Phone

(919) 474-6700

Address

4721 EMPEROR BOULEVARD, SUITE 100, DURHAM

Employee

940

Twitter

Next Earnings Date

2026-08-05

Latest SEC Filings

BVS's Discussions on Twitter

Compare BVS vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BVS Bioventus Inc	11.78	639.54M	568.09M	27.27M	71.41M	0.3276
ABT Abbott Laboratories	95.63	158.05B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	324.73	120.70B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	83.06	100.14B	36.36B	4.84B	5.43B	3.7212
BSX Boston Scientific Corp	44.60	63.44B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	95.18	52.09B	6.30B	1.07B	1.09B	1.8406

Bioventus Inc Stock (BVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-27-26	Initiated	CJS Securities	Market Outperform
Feb-09-26	Initiated	Barrington Research	Outperform
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Mar-15-22	Initiated	Craig Hallum	Buy
Nov-15-21	Resumed	Morgan Stanley	Overweight
Nov-10-21	Resumed	JP Morgan	Overweight
Jul-01-21	Downgrade	Goldman	Buy → Neutral
Mar-08-21	Initiated	Canaccord Genuity	Buy
Mar-08-21	Initiated	Goldman	Buy
Mar-08-21	Initiated	JP Morgan	Overweight
Mar-08-21	Initiated	Morgan Stanley	Overweight

View All

Bioventus Inc Stock (BVS) Latest News

Jun 30, 2026

The Technical Signals Behind (BVS) That Institutions Follow - Stock Traders Daily

Jun 30, 2026

Bioventus, Inc. Class A Revenue Breakdown – DUS:4B8 - TradingView

Jun 30, 2026

Average basic shares outstanding of Bioventus, Inc. Class A – DUS:4B8 - TradingView

Jun 30, 2026

Form DEF 14A Bioventus Inc For: 26 June By Investing.com - Investing.com Nigeria

Jun 27, 2026

Jun 26, 2026

Bioventus, Inc. Class A Actuals & Estimates (NASDAQ:BVS) - TradingView

Jun 26, 2026

Price to earnings forward of Bioventus, Inc. Class A – FWB:4B8 - TradingView

Jun 26, 2026

Price to earnings forward of Bioventus, Inc. Class A – TRADEGATE:4B8 - TradingView

Jun 26, 2026

Jun 25, 2026

Bioventus, Inc. Class A Actuals & Estimates (FWB:4B8) - TradingView

Jun 25, 2026

BVS Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

4B8 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Should Value Investors Buy Bioventus (BVS) Stock? - Yahoo Finance

Jun 25, 2026

Enterprise value to EBITDA forward of Bioventus, Inc. Class A – FWB:4B8 - TradingView

Jun 25, 2026

Jun 24, 2026

Enterprise value to revenue forward of Bioventus Inc. – NASDAQ:BVS - TradingView

Jun 24, 2026

Price to book forward of Bioventus Inc. – NASDAQ:BVS - TradingView

Jun 24, 2026

Jun 23, 2026

Long term debt to total equity ratio of Bioventus, Inc. Class A – FWB:4B8 - TradingView

Jun 23, 2026

Book value per share of Bioventus, Inc. Class A – FWB:4B8 - TradingView

Jun 23, 2026

Total debt per share of Bioventus, Inc. Class A – FWB:4B8 - TradingView

Jun 23, 2026

Bioventus, Inc. Class A Trade Ideas — FWB:4B8 - TradingView

Jun 23, 2026

Jun 20, 2026

BVS Technical Analysis & Stock Price Forecast - Intellectia AI

Jun 20, 2026

Jun 19, 2026

Precision Trading with Bioventus Inc. (BVS) Risk Zones - Stock Traders Daily

Jun 19, 2026

Jun 18, 2026